+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Decongestant Market by Product Type, Route Of Administration, Distribution Channel, End User, Prescription Status, Form - Global Forecast to 2030- Product Image
Decongestant Market by Product Type, Route Of Administration, Distribution Channel, End User, Prescription Status, Form - Global Forecast to 2030- Product Image
Sale

Decongestant Market by Product Type, Route Of Administration, Distribution Channel, End User, Prescription Status, Form - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6083037
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Decongestant Market grew from USD 7.03 billion in 2024 to USD 7.48 billion in 2025. It is expected to continue growing at a CAGR of 6.28%, reaching USD 10.13 billion by 2030.

Understanding the Rising Importance of Decongestant Therapies

The decongestant sector is experiencing unparalleled attention from industry stakeholders, healthcare providers, and consumers alike as respiratory health takes center stage in public discourse. Increasing prevalence of nasal congestion in the general population, driven by seasonal allergies, airborne pollutants, and viral infections, has fueled demand for rapid symptom relief. This introduction sets the stage by outlining the critical role decongestants play in contemporary wellness routines, illustrating how evolving consumer preferences and regulatory landscapes have converged to create a dynamic and rapidly transforming marketplace.

By tracing the roots of decongestant therapies from traditional herbal extracts to advanced formulations designed for targeted delivery, it becomes clear that innovation is a cornerstone of this industry. Differentiated modalities-ranging from easy-to-use nasal sprays to extended-release tablets-cater to diverse patient needs, while emerging digital health platforms provide new avenues for patient education and adherence. This comprehensive overview underscores why a detailed examination of recent market shifts and structural drivers is essential for organizations seeking to stay ahead in a competitive environment.

How Innovation and Consumer Trends Are Reshaping the Market

A convergence of scientific breakthroughs, regulatory encouragement, and shifting consumer behaviors has instigated transformative shifts across the decongestant landscape. Rapid advances in drug-delivery technologies, such as ultra-fine nebulization and precision metered-dose systems, have enhanced therapeutic efficacy while minimizing side effects. At the same time, regulatory bodies have streamlined approval pathways for novel formulations, incentivizing manufacturers to accelerate innovation.

Meanwhile, health-conscious consumers increasingly favor non-invasive treatment options, driving demand for nasal sprays and topical gels over oral medications in many demographics. Digital health tools, including telemedicine consultations and mobile health applications, are reshaping patient-provider interactions and enabling personalized symptom management strategies. As a result, industry participants are reconfiguring their supply chains, forming strategic alliances with biotechnology firms, and investing in real-world evidence studies to demonstrate comparative effectiveness. These collective shifts are redefining competitive boundaries and challenging traditional business models in ways that warrant careful analysis and proactive strategy development.

Navigating New Cost Structures Amid Shifting Trade Policies

United States tariffs implemented in early 2025 have introduced significant cost pressures throughout the decongestant supply chain. Increased duties on key raw materials and active pharmaceutical ingredients have led manufacturers to reassess sourcing strategies and negotiate new procurement agreements, while also exploring local production to mitigate exposure to trade fluctuations. Pharmaceutical firms reliant on global suppliers have encountered margin compression, prompting some to pass incremental costs to wholesalers and end users.

In parallel, downstream distribution partners have witnessed tighter price bands, compelling logistics providers and pharmacies to optimize inventory management and prioritize high-turnover products. Regulatory stipulations regarding drug pricing and reimbursement rates have further intensified the need for cost containment. These tariff-driven developments have reinvigorated conversations around vertical integration, risk diversification, and portfolio rationalization as companies seek sustainable ways to preserve profitability without compromising patient access or product quality.

Unlocking Opportunities Through Detailed Segment Analysis

A nuanced understanding of market segmentation is vital for crafting effective market entry and growth strategies. Analysis by product type reveals that drop formulations, encompassing both multi-dose and single-dose variants, continue to serve patients seeking minimal waste and controlled dosing. Metered-dose nasal sprays and standard spray alternatives offer complementary advantages of consistent drug delivery and ease of use, while tablets and capsules available in extended-release or immediate-release configurations address the needs of patients requiring sustained relief or rapid onset, respectively.

When exploring administration routes, the distinct advantages of topical nasal application-such as reduced systemic exposure and localized effect-contrast with the convenience of oral formulations that integrate seamlessly into daily medication routines. Distribution channels also exhibit clear differentiation. Hospital pharmacies, whether private or public, maintain their role as critical access points for acute care settings, while online platforms-hosted on branded websites or third-party marketplaces-continue to expand reach among tech-savvy consumers. Traditional retail outlets, spanning both chain and independent pharmacies, balance personalized service with widespread availability.

End-user categories encompass adults and geriatric populations, each presenting unique tolerability and comorbidity considerations, alongside pediatric patients, subdivided into adolescents, children, and infants, where safety and dosing precision are paramount. Understanding prescription dynamics further refines market opportunities, as over-the-counter options fulfill the needs of self-managing consumers, while prescription status products maintain clinician oversight for complex cases. Finally, form factor analysis, differentiating liquid suspensions and syrups from semi-solid gels and ointments and solid capsules and tablets, uncovers preferences for certain delivery systems under varying clinical and lifestyle scenarios.

Capitalizing on Distinct Regional Dynamics and Drivers

Regional dynamics present diverse growth imperatives and strategic priorities across the global decongestant industry. In the Americas, robust research infrastructure and extensive retail networks drive rapid adoption of advanced formulations, while insurance frameworks and consumer spending power support premium product segments. Meanwhile, changing regulatory guidelines in Europe, Middle East & Africa are streamlining market entry for innovative therapies, even as economic volatility in certain markets requires agile pricing and distribution approaches. Different patient demographics and healthcare accessibility patterns further shape demand in these regions.

Across Asia-Pacific, expanding middle-class populations, stronger healthcare investments, and rising awareness of respiratory wellness catalyze opportunities for both local and multinational players. Fragmented distribution ecosystems and varying registration timelines necessitate region-specific commercialization tactics. Companies are increasingly forging joint ventures and local partnerships to navigate regulatory nuances and cultural preferences, ensuring their decongestant offerings align with regional healthcare policies and patient expectations.

Profiling the Strategies Driving Market Leadership

Leading organizations continue to vie for market leadership through a blend of strategic alliances, product portfolio enhancements, and operational excellence. Key players have deployed targeted M&A activity to integrate novel delivery platforms and bolster their R&D pipelines. Meanwhile, agile mid-sized firms leverage niche expertise in metered-dose technology or pediatric formulations to carve out specialized segments. Collaborative initiatives with academic institutions and contract research organizations accelerate clinical validation of next-generation decongestants, while investments in smart manufacturing and quality-by-design methodologies improve efficiency and compliance.

In tandem, companies are sharpening their brand positioning through evidence-based marketing campaigns that emphasize comparative efficacy and patient-centric value propositions. Strategic supply chain partnerships and capacity expansions are reducing lead times and enhancing resilience against trade disruptions. As competition intensifies, the ability to rapidly translate scientific advances into scalable, cost-effective products will differentiate winners in this fast-evolving marketplace.

Actionable Strategies to Gain Competitive Edge

Industry leaders should prioritize innovation in targeted delivery systems by allocating resources toward research collaborations that refine metered-dose accuracy and foster customizable dosing options. They must also deepen engagement with healthcare professionals by sponsoring evidence generation studies that highlight real-world patient outcomes and cost-of-care advantages. To navigate shifting trade policies, companies should diversify supplier portfolios, invest in regional manufacturing capabilities, and negotiate flexible contracts that incorporate tariff contingencies.

Simultaneously, strengthening digital commerce capabilities is essential to capture growing segments of self-directed consumers. Developing intuitive mobile health applications and enhancing e-commerce platforms can improve customer experience, foster brand loyalty, and facilitate data-driven marketing. Finally, embracing sustainable practices-from eco-friendly packaging to waste reduction initiatives-will resonate with environmentally conscious stakeholders, further reinforcing corporate reputation and opening doors to green procurement frameworks.

Ensuring Research Rigor Through a Hybrid Analytical Framework

A rigorous mixed-methods approach underpins the research methodology, combining primary and secondary data sources to ensure comprehensive coverage of the decongestant market. Expert interviews with key opinion leaders, including clinical practitioners and regulatory specialists, were conducted to validate findings and uncover emerging trends. Secondary research encompassed the review of peer-reviewed journals, industry white papers, and publicly available regulatory filings.

Quantitative analysis involved mapping product pipelines, assessing distribution footprints, and evaluating corporate reports to profile competitive dynamics. Qualitative insights derived from stakeholder surveys and structured interviews provided context around shifting physician prescribing behaviors and patient preferences. Triangulation of multiple data inputs ensured robustness and minimized potential biases, resulting in a holistic perspective on market drivers, restraints, and strategic imperatives.

Concluding Insights to Guide Strategic Decision Making

In summary, the decongestant market stands at a crossroads of innovation, regulatory evolution, and shifting consumer expectations. Technological breakthroughs in drug-delivery systems, coupled with a proliferation of digital health tools, are redefining how patients access and manage relief from nasal congestion. Simultaneously, tariff schedules and regional regulatory reforms have introduced new challenges and opportunities that demand nimble, data-driven strategies.

By synthesizing segment-level insights, regional variations, and competitive intelligence, stakeholders can identify high-potential arenas for investment and collaboration. The strategic recommendations offered here will empower industry participants to optimize operations, differentiate product offerings, and engage target audiences effectively. As the market continues to evolve, ongoing vigilance and adaptability will be essential for sustaining growth and delivering value to patients worldwide.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Drops
      • Multi Dose
      • Single Dose
    • Nasal Sprays
      • Metered Dose
      • Standard Spray
    • Tablets & Capsules
      • Extended Release
      • Immediate Release
  • Route Of Administration
    • Nasal
    • Oral
  • Distribution Channel
    • Hospital Pharmacies
      • Private
      • Public
    • Online Pharmacies
      • Branded Websites
      • Third-Party Platforms
    • Retail Pharmacies
      • Chain Pharmacies
      • Independent Pharmacies
  • End User
    • Adults
    • Geriatric
    • Pediatrics
      • Adolescents
      • Children
      • Infants
  • Prescription Status
    • Over The Counter
    • Prescription
  • Form
    • Liquid
      • Suspension
      • Syrup
    • Semi Solid
      • Gel
      • Ointment
    • Solid
      • Capsule
      • Tablet
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Johnson & Johnson
  • Reckitt Benckiser Group plc
  • The Procter & Gamble Company
  • Haleon plc
  • Pfizer Inc.
  • Bayer AG
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Perrigo Company plc
  • Viatris Inc.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Decongestant Market, by Product Type
8.1. Introduction
8.2. Drops
8.2.1. Multi Dose
8.2.2. Single Dose
8.3. Nasal Sprays
8.3.1. Metered Dose
8.3.2. Standard Spray
8.4. Tablets & Capsules
8.4.1. Extended Release
8.4.2. Immediate Release
9. Decongestant Market, by Route Of Administration
9.1. Introduction
9.2. Nasal
9.3. Oral
10. Decongestant Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.2.1. Private
10.2.2. Public
10.3. Online Pharmacies
10.3.1. Branded Websites
10.3.2. Third-Party Platforms
10.4. Retail Pharmacies
10.4.1. Chain Pharmacies
10.4.2. Independent Pharmacies
11. Decongestant Market, by End User
11.1. Introduction
11.2. Adults
11.3. Geriatric
11.4. Pediatrics
11.4.1. Adolescents
11.4.2. Children
11.4.3. Infants
12. Decongestant Market, by Prescription Status
12.1. Introduction
12.2. Over The Counter
12.3. Prescription
13. Decongestant Market, by Form
13.1. Introduction
13.2. Liquid
13.2.1. Suspension
13.2.2. Syrup
13.3. Semi Solid
13.3.1. Gel
13.3.2. Ointment
13.4. Solid
13.4.1. Capsule
13.4.2. Tablet
14. Americas Decongestant Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Decongestant Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Decongestant Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Johnson & Johnson
17.3.2. Reckitt Benckiser Group plc
17.3.3. The Procter & Gamble Company
17.3.4. Haleon plc
17.3.5. Pfizer Inc.
17.3.6. Bayer AG
17.3.7. Sanofi S.A.
17.3.8. Teva Pharmaceutical Industries Ltd.
17.3.9. Perrigo Company plc
17.3.10. Viatris Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. DECONGESTANT MARKET MULTI-CURRENCY
FIGURE 2. DECONGESTANT MARKET MULTI-LANGUAGE
FIGURE 3. DECONGESTANT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DECONGESTANT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DECONGESTANT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DECONGESTANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DECONGESTANT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DECONGESTANT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DECONGESTANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DECONGESTANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DECONGESTANT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DECONGESTANT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DECONGESTANT MARKET SIZE, BY PRESCRIPTION STATUS, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DECONGESTANT MARKET SIZE, BY PRESCRIPTION STATUS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL DECONGESTANT MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 18. GLOBAL DECONGESTANT MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS DECONGESTANT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS DECONGESTANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES DECONGESTANT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES DECONGESTANT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA DECONGESTANT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA DECONGESTANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC DECONGESTANT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC DECONGESTANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. DECONGESTANT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. DECONGESTANT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DECONGESTANT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DECONGESTANT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DECONGESTANT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DECONGESTANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DECONGESTANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DECONGESTANT MARKET SIZE, BY DROPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DECONGESTANT MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DECONGESTANT MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DECONGESTANT MARKET SIZE, BY DROPS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DECONGESTANT MARKET SIZE, BY NASAL SPRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DECONGESTANT MARKET SIZE, BY METERED DOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DECONGESTANT MARKET SIZE, BY STANDARD SPRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DECONGESTANT MARKET SIZE, BY NASAL SPRAYS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DECONGESTANT MARKET SIZE, BY TABLETS & CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DECONGESTANT MARKET SIZE, BY EXTENDED RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DECONGESTANT MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DECONGESTANT MARKET SIZE, BY TABLETS & CAPSULES, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DECONGESTANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DECONGESTANT MARKET SIZE, BY NASAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DECONGESTANT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DECONGESTANT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DECONGESTANT MARKET SIZE, BY PRIVATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DECONGESTANT MARKET SIZE, BY PUBLIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DECONGESTANT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DECONGESTANT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DECONGESTANT MARKET SIZE, BY BRANDED WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DECONGESTANT MARKET SIZE, BY THIRD-PARTY PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DECONGESTANT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DECONGESTANT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DECONGESTANT MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DECONGESTANT MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DECONGESTANT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DECONGESTANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DECONGESTANT MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DECONGESTANT MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DECONGESTANT MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DECONGESTANT MARKET SIZE, BY ADOLESCENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DECONGESTANT MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DECONGESTANT MARKET SIZE, BY INFANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DECONGESTANT MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DECONGESTANT MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DECONGESTANT MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DECONGESTANT MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL DECONGESTANT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL DECONGESTANT MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL DECONGESTANT MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL DECONGESTANT MARKET SIZE, BY SYRUP, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL DECONGESTANT MARKET SIZE, BY LIQUID, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL DECONGESTANT MARKET SIZE, BY SEMI SOLID, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL DECONGESTANT MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL DECONGESTANT MARKET SIZE, BY OINTMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL DECONGESTANT MARKET SIZE, BY SEMI SOLID, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL DECONGESTANT MARKET SIZE, BY SOLID, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL DECONGESTANT MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL DECONGESTANT MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL DECONGESTANT MARKET SIZE, BY SOLID, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS DECONGESTANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS DECONGESTANT MARKET SIZE, BY DROPS, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS DECONGESTANT MARKET SIZE, BY NASAL SPRAYS, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS DECONGESTANT MARKET SIZE, BY TABLETS & CAPSULES, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS DECONGESTANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS DECONGESTANT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS DECONGESTANT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS DECONGESTANT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS DECONGESTANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS DECONGESTANT MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS DECONGESTANT MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS DECONGESTANT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS DECONGESTANT MARKET SIZE, BY LIQUID, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS DECONGESTANT MARKET SIZE, BY SEMI SOLID, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS DECONGESTANT MARKET SIZE, BY SOLID, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS DECONGESTANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES DECONGESTANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES DECONGESTANT MARKET SIZE, BY DROPS, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES DECONGESTANT MARKET SIZE, BY NASAL SPRAYS, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES DECONGESTANT MARKET SIZE, BY TABLETS & CAPSULES, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES DECONGESTANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES DECONGESTANT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES DECONGESTANT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES DECONGESTANT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES DECONGESTANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES DECONGESTANT MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES DECONGESTANT MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES DECONGESTANT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES DECONGESTANT MARKET SIZE, BY LIQUID, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES DECONGESTANT MARKET SIZE, BY SEMI SOLID, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES DECONGESTANT MARKET SIZE, BY SOLID, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES DECONGESTANT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 93. CANADA DECONGESTANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. CANADA DECONGESTANT MARKET SIZE, BY DROPS, 2018-2030 (USD MILLION)
TABLE 95. CANADA DECONGESTANT MARKET SIZE, BY NASAL SPRAYS, 2018-2030 (USD MILLION)
TABLE 96. CANADA DECONGESTANT MARKET SIZE, BY TABLETS & CAPSULES, 2018-2030 (USD MILLION)
TABLE 97. CANADA DECONGESTANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 98. CANADA DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. CANADA DECONGESTANT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 100. CANADA DECONGESTANT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 101. CANADA DECONGESTANT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 102. CANADA DECONGESTANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. CANADA DECONGESTANT MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 104. CANADA DECONGESTANT MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 105. CANADA DECONGESTANT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 106. CANADA DECONGESTANT MARKET SIZE, BY LIQUID, 2018-2030 (USD MILLION)
TABLE 107. CANADA DECONGESTANT MARKET SIZE, BY SEMI SOLID, 2018-2030 (USD MILLION)
TABLE 108. CANADA DECONGESTANT MARKET SIZE, BY SOLID, 2018-2030 (USD MILLION)
TABLE 109. MEXICO DECONGESTANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 110. MEXICO DECONGESTANT MARKET SIZE, BY DROPS, 2018-2030 (USD MILLION)
TABLE 111. MEXICO DECONGESTANT MARKET SIZE, BY NASAL SPRAYS, 2018-2030 (USD MILLION)
TABLE 112. MEXICO DECONGESTANT MARKET SIZE, BY TABLETS & CAPSULES, 2018-2030 (USD MILLION)
TABLE 113. MEXICO DECONGESTANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 114. MEXICO DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 115. MEXICO DECONGESTANT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 116. MEXICO DECONGESTANT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 117. MEXICO DECONGESTANT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 118. MEXICO DECONGESTANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. MEXICO DECONGESTANT MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 120. MEXICO DECONGESTANT MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 121. MEXICO DECONGESTANT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 122. MEXICO DECONGESTANT MARKET SIZE, BY LIQUID, 2018-2030 (USD MILLION)
TABLE 123. MEXICO DECONGESTANT MARKET SIZE, BY SEMI SOLID, 2018-2030 (USD MILLION)
TABLE 124. MEXICO DECONGESTANT MARKET SIZE, BY SOLID, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL DECONGESTANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL DECONGESTANT MARKET SIZE, BY DROPS, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL DECONGESTANT MARKET SIZE, BY NASAL SPRAYS, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL DECONGESTANT MARKET SIZE, BY TABLETS & CAPSULES, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL DECONGESTANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL DECONGESTANT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL DECONGESTANT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL DECONGESTANT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL DECONGESTANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL DECONGESTANT MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL DECONGESTANT MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL DECONGESTANT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL DECONGESTANT MARKET SIZE, BY LIQUID, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL DECONGESTANT MARKET SIZE, BY SEMI SOLID, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL DECONGESTANT MARKET SIZE, BY SOLID, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA DECONGESTANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA DECONGESTANT MARKET SIZE, BY DROPS, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA DECONGESTANT MARKET SIZE, BY NASAL SPRAYS, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA DECONGESTANT MARKET SIZE, BY TABLETS & CAPSULES, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA DECONGESTANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA DECONGESTANT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA DECONGESTANT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA DECONGESTANT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA DECONGESTANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA DECONGESTANT MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA DECONGESTANT MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA DECONGESTANT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 154. ARGENTINA DECONGESTANT MARKET SIZE, BY LIQUID, 2018-2030 (USD MILLION)
TABLE 155. ARGENTINA DECONGESTANT MARKET SIZE, BY SEMI SOLID, 2018-2030 (USD MILLION)
TABLE 156. ARGENTINA DECONGESTANT MARKET SIZE, BY SOLID, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA DECONGESTANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA DECONGESTANT MARKET SIZE, BY DROPS, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA DECONGESTANT MARKET SIZE, BY NASAL SPRAYS, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA DECONGESTANT MARKET SIZE, BY TABLETS & CAPSULES, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA DECONGESTANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA DECONGESTANT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA DECONGESTANT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA DECONGESTANT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA DECONGESTANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA DECONGESTANT MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA DECONGESTANT MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA DECONGESTANT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA DECONGESTANT MARKET SIZE, BY LIQUID, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA DECONGESTANT MARKET SIZE, BY SEMI SOLID, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA DECONGESTANT MARKET SIZE, BY SOLID, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA DECONGESTANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 174. UNITED KINGDOM DECONGESTANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM DECONGESTANT MARKET SIZE, BY DROPS, 2018-2030 (USD MILLION)
TABLE 176. UNITED KINGDOM DECONGESTANT MARKET SIZE, BY NASAL SPRAYS, 2018-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM DECONGESTANT MARKET SIZE, BY TABLETS & CAPSULES, 2018-2030 (USD MILLION)
TABLE 178. UNITED KINGDOM DECONGESTANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. UNITED KINGDOM DECONGESTANT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM DECONGESTANT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 182. UNITED KINGDOM DECONGESTANT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM DECONGESTANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM DECONGESTANT MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM DECONGESTANT MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM DECONGESTANT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM DECONGESTANT MARKET SIZE, BY LIQUID, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM DECONGESTANT MARKET SIZE, BY SEMI SOLID, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM DECONGESTANT MARKET SIZE, BY SOLID, 2018-2030 (USD MILLION)
TABLE 190. GERMANY DECONGESTANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 191. GERMANY DECONGESTANT MARKET SIZE, BY DROPS, 2018-2030 (USD MILLION)
TABLE 192. GERMANY DECONGESTANT MARKET SIZE, BY NASAL SPRAYS, 2018-2030 (USD MILLION)
TABLE 193. GERMANY DECONGESTANT MARKET SIZE, BY TABLETS & CAPSULES, 2018-2030 (USD MILLION)
TABLE 194. GERMANY DECONGESTANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 195. GERMANY DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 196. GERMANY DECONGESTANT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 197. GERMANY DECONGESTANT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 198. GERMANY DECONGESTANT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 199. GERMANY DECONGESTANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. GERMANY DECONGESTANT MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 201. GERMANY DECONGESTANT MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 202. GERMANY DECONGESTANT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 203. GERMANY DECONGESTANT MARKET SIZE, BY LIQUID, 2018-2030 (USD MILLION)
TABLE 204. GERMANY DECONGESTANT MARKET SIZE, BY SEMI SOLID, 2018-2030 (USD MILLION)
TABLE 205. GERMANY DECONGESTANT MARKET SIZE, BY SOLID, 2018-2030 (USD MILLION)
TABLE 206. FRANCE DECONGESTANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. FRANCE DECONGESTANT MARKET SIZE, BY DROPS, 2018-2030 (USD MILLION)
TABLE 208. FRANCE DECONGESTANT MARKET SIZE, BY NASAL SPRAYS, 2018-2030 (USD MILLION)
TABLE 209. FRANCE DECONGESTANT MARKET SIZE, BY TABLETS & CAPSULES, 2018-2030 (USD MILLION)
TABLE 210. FRANCE DECONGESTANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 211. FRANCE DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. FRANCE DECONGESTANT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 213. FRANCE DECONGESTANT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 214. FRANCE DECONGESTANT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 215. FRANCE DECONGESTANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. FRANCE DECONGESTANT MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 217. FRANCE DECONGESTANT MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 218. FRANCE DECONGESTANT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 219. FRANCE DECONGESTANT MARKET SIZE, BY LIQUID, 2018-2030 (USD MILLION)
TABLE 220. FRANCE DECONGESTANT MARKET SIZE, BY SEMI SOLID, 2018-2030 (USD MILLION)
TABLE 221. FRANCE DECONGESTANT MARKET SIZE, BY SOLID, 2018-2030 (USD MILLION)
TABLE 222. RUSSIA DECONGESTANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 223. RUSSIA DECONGESTANT MARKET SIZE, BY DROPS, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA DECONGESTANT MARKET SIZE, BY NASAL SPRAYS, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA DECONGESTANT MARKET SIZE, BY TABLETS & CAPSULES, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA DECONGESTANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA DECONGESTANT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA DECONGESTANT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA DECONGESTANT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA DECONGESTANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA DECONGESTANT MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA DECONGESTANT MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA DECONGESTANT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 235. RUSSIA DECONGESTANT MARKET SIZE, BY LIQUID, 2018-2030 (USD MILLION)
TABLE 236. RUSSIA DECONGESTANT MARKET SIZE, BY SEMI SOLID, 2018-2030 (USD MILLION)
TABLE 237. RUSSIA DECONGESTANT MARKET SIZE, BY SOLID, 2018-2030 (USD MILLION)
TABLE 238. ITALY DECONGESTANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 239. ITALY DECONGESTANT MARKET SIZE, BY DROPS, 2018-2030 (USD MILLION)
TABLE 240. ITALY DECONGESTANT MARKET SIZE, BY NASAL SPRAYS, 2018-2030 (USD MILLION)
TABLE 241. ITALY DECONGESTANT MARKET SIZE, BY TABLETS & CAPSULES, 2018-2030 (USD MILLION)
TABLE 242. ITALY DECONGESTANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 243. ITALY DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 244. ITALY DECONGESTANT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 245. ITALY DECONGESTANT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 246. ITALY DECONGESTANT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 247. ITALY DECONGESTANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. ITALY DECONGESTANT MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 249. ITALY DECONGESTANT MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 250. ITALY DECONGESTANT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 251. ITALY DECONGESTANT MARKET SIZE, BY LIQUID, 2018-2030 (USD MILLION)
TABLE 252. ITALY DECONGESTANT MARKET SIZE, BY SEMI SOLID, 2018-2030 (USD MILLION)
TABLE 253. ITALY DECONGESTANT MARKET SIZE, BY SOLID, 2018-2030 (USD MILLION)
TABLE 254. SPAIN DECONGESTANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 255. SPAIN DECONGESTANT MARKET SIZE, BY DROPS, 2018-2030 (USD MILLION)
TABLE 256. SPAIN DECONGESTANT MARKET SIZE, BY NASAL SPRAYS, 2018-2030 (USD MILLION)
TABLE 257. SPAIN DECONGESTANT MARKET SIZE, BY TABLETS & CAPSULES, 2018-2030 (USD MILLION)
TABLE 258. SPAIN DECONGESTANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 259. SPAIN DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 260. SPAIN DECONGESTANT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 261. SPAIN DECONGESTANT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 262. SPAIN DECONGESTANT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 263. SPAIN DECONGESTANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. SPAIN DECONGESTANT MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 265. SPAIN DECONGESTANT MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 266. SPAIN DECONGESTANT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 267. SPAIN DECONGESTANT MARKET SIZE, BY LIQUID, 2018-2030 (USD MILLION)
TABLE 268. SPAIN DECONGESTANT MARKET SIZE, BY SEMI SOLID, 2018-2030 (USD MILLION)
TABLE 269. SPAIN DECONGESTANT MARKET SIZE, BY SOLID, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES DECONGESTANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES DECONGESTANT MARKET SIZE, BY DROPS, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES DECONGESTANT MARKET SIZE, BY NASAL SPRAYS, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES DECONGESTANT MARKET SIZE, BY TABLETS & CAPSULES, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES DECONGESTANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES DECONGESTANT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES DECONGESTANT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES DECONGESTANT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES DECONGESTANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES DECONGESTANT MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES DECONGESTANT MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES DECONGESTANT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES DECONGESTANT MARKET SIZE, BY LIQUID, 2018-2030 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES DECONGESTANT MARKET SIZE, BY SEMI SOLID, 2018-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES DECONGESTANT MARKET SIZE, BY SOLID, 2018-2030 (USD MILLION)
TABLE 286. SAUDI ARABIA DECONGESTANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 287. SAUDI ARABIA DECONGESTANT MARKET SIZE, BY DROPS, 2018-2030 (USD MILLION)
TABLE 288. SAUDI ARABIA DECONGESTANT MARKET SIZE, BY NASAL SPRAYS, 2018-2030 (USD MILLION)
TABLE 289. SAUDI ARABIA DECONGESTANT MARKET SIZE, BY TABLETS & CAPSULES, 2018-2030 (USD MILLION)
TABLE 290. SAUDI ARABIA DECONGESTANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 291. SAUDI ARABIA DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 292. SAUDI ARABIA DECONGESTANT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA DECONGESTANT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 294. SAUDI ARABIA DECONGESTANT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA DECONGESTANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 296. SAUDI ARABIA DECONGESTANT MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA DECONGESTANT MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 298. SAUDI ARABIA DECONGESTANT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA DECONGESTANT MARKET SIZE, BY LIQUID, 2018-2030 (USD MILLION)
TABLE 300. SAUDI ARABIA DECONGESTANT MARKET SIZE, BY SEMI SOLID, 2018-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA DECONGESTANT MARKET SIZE, BY SOLID, 2018-2030 (USD MILLION)
TABLE 302. SOUTH AFRICA DECONGESTANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 303. SOUTH AFRICA DECONGESTANT MARKET SIZE, BY DROPS, 2018-2030 (USD MILLION)
TABLE 304. SOUTH AFRICA DECONGESTANT MARKET SIZE, BY NASAL SPRAYS, 2018-2030 (USD MILLION)
TABLE 305. SOUTH AFRICA DECONGESTANT MARKET SIZE, BY TABLETS & CAPSULES, 2018-2030 (USD MILLION)
TABLE 306. SOUTH AFRICA DECONGESTANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 307. SOUTH AFRICA DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 308. SOUTH AFRICA DECONGESTANT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 309. SOUTH AFRICA DECONGESTANT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 310. SOUTH AFRICA DECONGESTANT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA DECONGESTANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 312. SOUTH AFRICA DECONGESTANT MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA DECONGESTANT MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 314. SOUTH AFRICA DECONGESTANT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA DECONGESTANT MARKET SIZE, BY LIQUID, 2018-2030 (USD MILLION)
TABLE 316. SOUTH AFRICA DECONGESTANT MARKET SIZE, BY SEMI SOLID, 2018-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA DECONGESTANT MARKET SIZE, BY SOLID, 2018-2030 (USD MILLION)
TABLE 318. DENMARK DECONGESTANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 319. DENMARK DECONGESTANT MARKET SIZE, BY DROPS, 2018-2030 (USD MILLION)
TABLE 320. DENMARK DECONGESTANT MARKET SIZE, BY NASAL SPRAYS, 2018-2030 (USD MILLION)
TABLE 321. DENMARK DECONGESTANT MARKET SIZE, BY TABLETS & CAPSULES, 2018-2030 (USD MILLION)
TABLE 322. DENMARK DECONGESTANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 323. DENMARK DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 324. DENMARK DECONGESTANT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 325. DENMARK DECONGESTANT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 326. DENMARK DECONGESTANT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 327. DENMARK DECONGESTANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 328. DENMARK DECONGESTANT MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 329. DENMARK DECONGESTANT MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 330. DENMARK DECONGESTANT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 331. DENMARK DECONGESTANT MARKET SIZE, BY LIQUID, 2018-2030 (USD MILLION)
TABLE 332. DENMARK DECONGESTANT MARKET SIZE, BY SEMI SOLID, 2018-2030 (USD MILLION)
TABLE 333. DENMARK DECONGESTANT MARKET SIZE, BY SOLID, 2018-2030 (USD MILLION)
TABLE 334. NETHERLANDS DECONGESTANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 335. NETHERLANDS DECONGESTANT MARKET SIZE, BY DROPS, 2018-2030 (USD MILLION)
TABLE 336. NETHERLANDS DECONGESTANT MARKET SIZE, BY NASAL SPRAYS, 2018-2030 (USD MILLION)
TABLE 337. NETHERLANDS DECONGESTANT MARKET SIZE, BY TABLETS & CAPSULES, 2018-2030 (USD MILLION)
TABLE 338. NETHERLANDS DECONGESTANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 339. NETHERLANDS DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 340. NETHERLANDS DECONGESTANT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 341. NETHERLANDS DECONGESTANT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 342. NETHERLANDS DECONGESTANT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 343. NETHERLANDS DECONGESTANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 344. NETHERLANDS DECONGESTANT MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 345. NETHERLANDS DECONGESTANT MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 346. NETHERLANDS DECONGESTANT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 347. NETHERLANDS DECONGESTANT MARKET SIZE, BY LIQUID, 2018-2030 (USD MILLION)
TABLE 348. NETHERLANDS DECONGESTANT MARKET SIZE, BY SEMI SOLID, 2018-2030 (USD MILLION)
TABLE 349. NETHERLANDS DECONGESTANT MARKET SIZE, BY SOLID, 2018-2030 (USD MILLION)
TABLE 350. QATAR DECONGESTANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 351. QATAR DECONGESTANT MARKET SIZE, BY DROPS, 2018-2030 (USD MILLION)
TABLE 352. QATAR DECONGESTANT MARKET SIZE, BY NASAL SPRAYS, 2018-2030 (USD MILLION)
TABLE 353. QATAR DECONGESTANT MARKET SIZE, BY TABLETS & CAPSULES, 2018-2030 (USD MILLION)
TABLE 354. QATAR DECONGESTANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 355. QATAR DECONGESTANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 356. QATAR DECONGESTANT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 357. QATAR DECONGESTANT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 358. QATAR DECONGESTANT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 359. QATAR DECONGESTANT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 360. QATAR DECONGESTANT MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
TABLE 361. QATAR DECONGESTANT MARKET SIZE, BY PRESCRIPTION STATUS, 2018-2030 (USD MILLION)
TABLE 362. QATAR DECONGESTANT MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 363. QATAR DECONGESTANT MARKET SIZE, BY LIQUID, 2018-2030 (USD MILLION)
TABLE 364. QATAR DECONGESTANT MARKET SIZE, BY SEMI SOLID, 2018-2030 (USD MILLION)
TABLE 365. QATAR DECONGESTANT MARKET SIZE, BY SOLID, 2018-2030 (USD MILLION)
TABLE 366. FINLAND DECONGESTANT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 367. FINLAND DECONGESTANT MARKET SIZE, BY DROPS,

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Decongestant market report include:
  • Johnson & Johnson
  • Reckitt Benckiser Group plc
  • The Procter & Gamble Company
  • Haleon plc
  • Pfizer Inc.
  • Bayer AG
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Perrigo Company plc
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages183
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 7.48 Billion
Forecasted Market Value ( USD ) by 2030 $ 10.13 Billion
Compound Annual Growth Rate6.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Sinusitis Drugs Market 2024-2028 - Product Image

Sinusitis Drugs Market 2024-2028

  • Report
  • 178 Pages
  • Global
From
Cough and Cold Preparation Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Cough and Cold Preparation Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Chronic Cough Market Report 2025 - Product Image

Chronic Cough Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Cough, Cold and Allergy (Hay Fever) Remedies in Brazil - Product Image

Cough, Cold and Allergy (Hay Fever) Remedies in Brazil

  • Report
  • 28 Pages
  • Brazil
From
Cough Remedies Market Report 2025 - Product Image

Cough Remedies Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Decongestant Market

The Decongestant market is a subset of the Cough and Cold Drugs market, which includes medications used to treat symptoms of the common cold, such as nasal congestion, sinus pressure, and chest congestion. Decongestants are typically available in both over-the-counter (OTC) and prescription forms, and are often used in combination with other medications to treat cold and flu symptoms. Decongestants work by narrowing the blood vessels in the nasal passages, reducing inflammation and allowing for easier breathing. Common OTC decongestants include pseudoephedrine, phenylephrine, and oxymetazoline. Prescription decongestants include ephedrine, phenylephrine, and phenylpropanolamine. Decongestants are also available in combination with other medications, such as antihistamines, expectorants, and cough suppressants. Some companies in the Decongestant market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Novartis, Merck, and Sanofi. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.